Evaluation of a selective medium for isolation of Haemophilus pleuropneumoniae.
Crystal violet, lincomycin, spectinomycin and bacitracin were evaluated as selective agents in media for isolation of Haemophilus pleuropneumoniae. No single antimicrobial agent or combination of two or more inhibited all non-Haemophilus strains (Escherichia coli, Pasteurella haemolytica, Pasteurella multocida, Streptococcus faecalis, Streptococcus equisimilis and Staphylococcus aureus) without marked suppression of 16 H. pleuropneumoniae strains. A medium containing 1 micrograms/mL of crystal violet, 1 microgram/mL of lincomycin, 8 micrograms/mL of spectinomycin and 128 micrograms/mL of bacitracin inhibited one E. coli strain and the Gram-positive strains while H. pleuropneumoniae strains were suppressed to a minor degree only. Haemophilus pleuropneumoniae was isolated on the selective medium on three occasions from the nose or pharynx of two out of eight experimentally inoculated pigs. Haemophilus pleuropneumoniae was recovered from the nose of only two pigs at necropsy and from tonsil of one, whereas the lower airways in most pigs and the lung lesions in all pigs were positive. There was no advantage to using the selective medium for the recovery of H. pleuropneumoniae at necropsy from these eight experimentally infected pigs, probably because other bacteria were absent or present in very low numbers in the tissues with H. pleuropneumoniae. The isolation rate on selective medium was higher than the rate on non-selective medium (p less than or equal to 0.1; chi 2 test) when the airways of slaughtered pigs were cultured. This was likely due to a high degree of contamination. Dry swabs placed in tryptone yeast extract with nicotinamide-adenine-dinucleotide gave a significantly higher recovery rate than commercial Culturette swabs in modified Stuart's transport medium.(ABSTRACT TRUNCATED AT 250 WORDS)
D000362:Agar; D000818:Animals; D001414:Bacitracin / Q000494:pharmacology; D001431:Bacteriological Techniques / Q000662:veterinary; D002353:Carrier State / Q000382:microbiology / Q000662:veterinary*; D002364:Caseins; D003470:Culture Media; D005840:Gentian Violet / Q000494:pharmacology; D006190:Haemophilus / Q000145:classification / Q000302:isolation & purification*; D006192:Haemophilus Infections / Q000382:microbiology / Q000662:veterinary*; D008034:Lincomycin / Q000494:pharmacology; D011001:Pleuropneumonia / Q000382:microbiology / Q000662:veterinary*; D011492:Protein Hydrolysates; D012703:Serotyping / Q000662:veterinary; D000198:Spectinomycin / Q000494:pharmacology; D013552:Swine / Q000382:microbiology; D013553:Swine Diseases / Q000382:microbiology*
D002364:Caseins; D003470:Culture Media; D011492:Protein Hydrolysates; C026375:trypticase-soy broth; D001414:Bacitracin; D000362:Agar; D000198:Spectinomycin; D008034:Lincomycin; D005840:Gentian Violet